Barely Significant
← all excerpts

Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease.

Blood Adv · 2026 · PMC13083646 · PMID 41628318

Europe PMCDOI
1
hedged sentence
0.0540
closest p · 1.1× alpha
0.0540
boldest claim

The sentences

showed a trendP = .054so close (0.05 < p ≤ 0.1)
Nontreosulfan-based MAC showed a trend toward increased mortality compared with RIC (HR, 4.0; 95% CI, 1.0-16.2; P = .054).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.